Patients' understanding of risk

British Medical Journal

Volumn 327, Issue 7417, 2003, Pages 693-694

  Thornton, Hazel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; PROSTATE SPECIFIC ANTIGEN;

BREAST CANCER; CANCER RISK; COMPETENCE; COMPREHENSION; CONSULTATION; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; EXPERIENCE; HEALTH CARE POLICY; HEALTH PRACTITIONER; HUMAN; INTERPERSONAL COMMUNICATION; MASS MEDIUM; MEDICAL DECISION MAKING; MEDICAL ETHICS; MENOPAUSAL SYNDROME; METASTASIS; PATIENT ATTITUDE; PATIENT INFORMATION; PERCEPTION; PRIORITY JOURNAL; PROPHYLAXIS; PROSTATE CANCER; RESPONSIBILITY; RISK; RISK BENEFIT ANALYSIS; SIDE EFFECT; SKILL; SOCIAL ASPECT; SOCIAL ENVIRONMENT;

EID: 0141757398     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7417.693     Document Type: Editorial

References (12)

1. Marshall T, Adab P. Informed consent for breast screening: what should we tell women? J Med Screening 2003;10:22-6.
2. Willis, K, Baxter J. Trusting technology: women aged 40-49 years participating in screening for breast cancer - an exploratory study. Austr N Z J Public Health 2003;27:282-6.
3. Chapple A, Ziebland S, Shepperd S, Miller R, Herxheimer A, McPherson A. Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study. BMJ 2002;325:737-9.
4. Lerner BH. The breast cancer wars. Hope, fear and the pursuit of a cure in twentieth-century America. New York: Oxford University, Press, 2001.
5. Gigerenzer G. Reckoning with risk. Learning to live with uncertainty. London: Peuguin Books, 2002.
6. Wragg JA, Robinson EJ, Lilford RJ. Information presentation and decision to enter clinical trials: a hypothetical trial of hormone replacement therapy. Soc Sci Med 2000;51:453-62.
7. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981;211:453-8.
8. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet 2003;362:419-27.
9. Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early breast cancer. Breast Cancer Res Treat 2003;77:2855-93.
10. Thornton H, Edwards A, Elwyn G. Evolving the multiple roles of "patients" in hearth-care research: reflections after involvement in a trial of shared decision-making. Health Expectations 2003;6(3):189-97. www.healthinpartnership.org/studies/edwards.html (accessed 11 Sep 2003.)
11. Thornton H. Anastrozole as a preventive agent in breast cancer. Lancet 2003;362:1911-2.
12. Refractor. Uncertainty. Lancet 2001;358:1090.